A new study led by investigators from Mass General Brigham has identified a unique brain network that links varied patterns ...

AstraZeneca and MSD's PARP inhibitor Lynparza has improved long-term survival when given as adjuvant therapy for early breast ...

At a time when fundamental questions are being posed about medical science, writes Jennifer Handt, let us not forget the beauty of it, the existential poetry and shared humanity that drives us toward ...

The Institute of Cancer Research, London, is the second-ranked academic research centre in the UK - according to the Times Higher Education league table of university research quality and impact ...

The Institute of Cancer Research, London, is a leading academic research centre in the UK and has achieved many awards that recognise the excellence of our teaching and research.

After a median follow-up of 6.1 years, patients treated with Lynparza continued to show significant improvements in survival ...